Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD PatientsTerminated
NCT03523728Phase 2, Phase 3Updated Feb 3, 2023
Sponsor: Genzyme, a Sanofi Company
Polycystic Kidney, Autosomal Dominant
United States, Argentina, Australia, Austria, Belgium +18 more
A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of Participants From PEDISTAD Study (OBS15333; NCT03687359)Completed
NCT05235724N/AUpdated Jan 31, 2023
Sponsor: Sanofi
Dermatitis Atopic
United States
Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )Completed
NCT03054727N/AUpdated Jan 23, 2023
Sponsor: Association des Médecins Vasculaires Hospitaliers
Post Thrombotic Syndrome · Venous Thromboembolism · Cardiovascular Diseases
France
Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma.Completed
NCT03884842Phase 3Updated Jan 20, 2023
Sponsor: McMaster University
Asthma
Canada
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of RelapseCompleted
NCT00055731Phase 3Updated Jan 18, 2023
Sponsor: UNICANCER
Prostate Cancer
France
Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in CambodiaCompleted
NCT05684185N/AUpdated Jan 13, 2023
Sponsor: Institut Pasteur du Cambodge
Rabies Post-exposure Prophylaxis
Cambodia
Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone With Carfilzomib in Relapsed or Refractory Multiple MyelomaUnknown
NCT04287855Phase 2Updated Jan 10, 2023
Sponsor: Poitiers University Hospital
Multiple Myeloma in Relapse · Multiple Myeloma, Refractory
France
Pregnancy, Arsenic and Immune ResponseCompleted
NCT03930017N/AUpdated Jan 5, 2023
Sponsor: Johns Hopkins Bloomberg School of Public Health
Arsenic--Toxicology · Immunologic Disorders Complicating Pregnancy · Vaccine Response Impaired · Micronutrient Deficiency
Bangladesh
Efficacy and Safety Study of Dupilumab in Patients With Persistent AsthmaCompleted
NCT03782532Phase 3Updated Dec 28, 2022
Sponsor: Sanofi
Asthma
China, India
A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood TransfusionCompleted
NCT03347422Phase 3Updated Dec 23, 2022
Sponsor: Bioverativ, a Sanofi company
Cold Agglutinin Disease
United States, Australia, Austria, Belgium, Canada +9 more
Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune ResponsesCompleted
NCT02555540Phase 4Updated Dec 20, 2022
Sponsor: University Hospital, Ghent
Prevention of Infections With Bordetella Pertussis
Belgium
Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)Completed
NCT05263193N/AUpdated Dec 14, 2022
Sponsor: Sanofi
Immune-mediated Thrombocytopenic Purpura
France
Comparative Efficacy of Cemiplimab to Historical Standard of Care in FranceCompleted
NCT05302297N/AUpdated Dec 13, 2022
Sponsor: Sanofi
Cancer/Squamous Cell Carcinoma of Skin
France
Genotype Information and Functional Testing StudyCompleted
NCT00992420N/AUpdated Nov 23, 2022
Sponsor: Scripps Health
Coronary Artery Disease
United States
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)Completed
NCT03546907Phase 2Updated Nov 22, 2022
Sponsor: Sanofi
Chronic Obstructive Pulmonary Disease
United States, Argentina, Australia, Canada, Chile +5 more
A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the PenisCompleted
NCT03114254Phase 2Updated Nov 18, 2022
Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust
Penile Neoplasm
United Kingdom
Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph NodesCompleted
NCT00433589Phase 3Updated Nov 17, 2022
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Breast Cancer
Netherlands
REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung CancerTerminated
NCT03515629Phase 3Updated Nov 16, 2022
Sponsor: Regeneron Pharmaceuticals
Non-small Cell Lung Cancer
United States, Italy, Lithuania
Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes PatientsCompleted
NCT04075513Phase 4Updated Nov 14, 2022
Sponsor: Sanofi
Type 1 Diabetes Mellitus
United States, Brazil, Germany, Hungary, Netherlands +2 more
Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza VaccineCompleted
NCT03430089Phase 1Updated Nov 9, 2022
Sponsor: Sanofi Pasteur, a Sanofi Company
Influenza · Flu
China
A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney DiseaseCompleted
NCT01559363Phase 1, Phase 2Updated Nov 8, 2022
Sponsor: Kadmon, a Sanofi Company
Polycystic Kidney, Autosomal Dominant
United States
A Study of REGN2810 and Ipilimumab in Patients With Lung CancerTerminated
NCT03430063Phase 2Updated Nov 3, 2022
Sponsor: Regeneron Pharmaceuticals
Advanced Non-Small Cell Lung Carcinoma
United States, Belgium, France, Germany, Poland +4 more
A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study)Completed
NCT03347396Phase 3Updated Oct 31, 2022
Sponsor: Bioverativ, a Sanofi company
Agglutinin Disease, Cold
United States, Australia, Austria, Belgium, Canada +9 more
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskTerminated
NCT03315143Phase 3Updated Oct 28, 2022
Sponsor: Lexicon Pharmaceuticals
Heart Failure · Type 2 Diabetes Mellitus · Chronic Kidney Diseases
United States, Argentina, Australia, Belgium, Brazil +40 more
Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)Terminated
NCT03521934Phase 3Updated Oct 28, 2022
Sponsor: Lexicon Pharmaceuticals
Heart Failure · Type 2 Diabetes Mellitus
United States, Argentina, Australia, Austria, Belgium +27 more

Previous page Next page